Consistent with this, Jimenez-Velasco et al.35 found LATS1 and LATS2 to be downregulated in leukemia as a consequence of their hypermethylation, and reduced LATS2 expression has been found to be associated with worse outcomes among leukemia patients. This evidence concerns the gene LATS1 and leukemia.